Meet our team
Experienced pharma leaders focused on one goal: bringing differentiated medicines to the patients who need them.
Serves as Chief Executive Officer of Kesin Pharma Corporation, where he leads the company's overall strategy and growth across its pharmaceutical portfolio, regulatory affairs, R&D, and quality operations. He brings nearly 20 years of start-up execution and leadership to the company, guiding Kesin's expansion in the institutional healthcare market.
Over the course of his career, David has directed FDA approvals for more than 200 ANDAs and NDAs and led FDA inspections across three continents. He previously served as Vice President at Xiromed, where he oversaw regulatory, quality, portfolio, and business development. His background spans the full product lifecycle, from regulatory and R&D through quality and commercialization.
Serves as Chief Operating Officer and Partner at Kesin Pharma Corporation, where he leads operations for the company's pharmaceutical repackaging and wholesale distribution business serving the institutional healthcare market. Under his leadership, Kesin supplies unit dose OTC and Rx products to healthcare facilities nationwide through partnerships with the industry's leading distributors, including McKesson, Cardinal Health, Cencora, and Morris & Dickson.
With a career spanning pharmaceutical quality control, analytical research and development, and GMP manufacturing, Justin brings deep regulatory and operational expertise to the company. He previously held positions as QC Manager at Cambrex and Analytical R&D Chemist at Catalent and Vista Pharma. He holds a Master of Public Health from West Virginia University and maintains expertise across 21 CFR, DSCSA, and DEA diversion control frameworks.
Steve is a seasoned pharmaceutical sales professional with over 25 years of industry experience. He has held key roles at companies such as APP (now Fresenius-Kabi), AuroMedics (Aurobindo USA), Sagent Pharmaceuticals, and Amneal Biosciences, where he led national accounts and managed relationships with major GPOs, IDNs, and distributors. Throughout his career, he has driven product placement strategies and improved contracting
protocols across multiple channels.
Most recently, Steven served as Vice President of Sales at Xiromed, LLC he holds a Bachelor of Arts degree f rom Northeastern Illinois University.
Currently serving as Executive Vice President of Business Development & Portfolio Management at Kesin Pharma, where over the last two years he has helped transform the company’s portfolio from a handful of products to more than 50 commercial products, while building a pipeline of several hundred additional opportunities. He has established strategic collaborations with many of the world’s leading generic pharmaceutical manufacturers and ANDA holders, creating a diverse network of supplier and development partnerships that have driven significant revenue growth, expanded market access, and accelerated portfolio development across hospital, institutional, retail, and specialty pharmaceutical channels.
Third Generation Generic Pharmaceutical executive with more than 24 years of experience in generic and specialty pharmaceuticals, business development, licensing, portfolio management, and strategic partnerships. Former Vice President of Business Development at Ascend Laboratories, where he led pipeline expansion, licensing, and commercial growth initiatives, and later directed Business Development and Finished Dose operations at SST Corporation.
Charles Sbarbaro brings over 40 years of pharmacy experience, with a career spanning hospital systems, GPOs, and pharmaceutical companies. He spent 18 years at Loyola University Medical Center managing pharmacy inventory and purchasing, and later served as a contract director at major GPOs such as Consorta and HealthTrust.
Charles has also led contracting departments at Sagent Pharmaceuticals and Kesin Pharma, negotiating a wide range of agreements for pharmaceuticals, distribution, and pharmacy- related capital equipment. He graduated with honors f rom Roosevelt University in 1997.
Phil White serves as National Sales Director at Kesin Pharma, where he leads the company's national sales strategy and commercial growth across the hospital and acute care markets. With more than 15 years of experience in pharmaceutical and healthcare sales, he specializes in helping health systems improve patient care through innovative pharmaceutical solutions.
Throughout his career, Phil has specialized in strategic account management for some of the country's largest Integrated Delivery Networks (IDNs), building long-standing relationships with health system executives and pharmacy leaders. He has built and scaled high-performing sales teams, led product commercialization initiatives, and developed strategic partnerships with GPOs, wholesalers, and other industry stakeholders.
Before joining Kesin, Phil also helped scale hospital automation solutions at Richtech Robotics, expanding his expertise in healthcare technology and operational innovation. Today, he leverages his deep expertise in IDN strategy, commercialization, and commercial execution to accelerate Kesin's growth and expand access to cost-effective pharmaceutical solutions nationwide.
